| Registry | NCT00018187 |
|---|---|
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional; non randomized, single group, masking: none, treatment |
| Sponsor | US Department of Veterans Affairs (Fed) |
| Conditions | Smoking |
| Interventions | Bupropion, Mecamylamine, Nicotine Patch (Drug) |
| Dates | start 1998-11-01, completion 2001-06-01, first posted 2001-07-05, last updated 2009-01-21 |
| Locations | 1 site in United States |
Related Papers Related Patents Related Grants Related Experts
All trials for Smoking All trials of Bupropion All trials of Mecamylamine
The purpose of this study is to test the effectiveness of a combination of the drugs bupropion and mecamylamine along with a nicotine patch as a therapy for smoking cessation.
Sex: All, ages: 20 Years to 40 Years
Subjects must be a smoker between 20 and 40 years old, have smoked at least 20 cigarettes per day for at least 2 years, wish to stop smoking and be in good general health
| Facility | City | Country | Status |
|---|---|---|---|
| VA Greater Los Angeles Healthcare System | Los Angeles, California | United States |